Figure 2.

Patients receiving maintenance PARPi had more favorable outcomes with BRCAalt but not BRCA-WT. rwPFS is shown by maintenance therapy received for (A) BRCAalt and (B) BRCA-WT. rwOS is shown by maintenance therapy received for (C) BRCAalt and (D) BRCA-WT. rwOS estimates are risk set adjusted to account for delayed entry to at-risk table (see “Materials and Methods”). Kaplan–Meier curves are adjusted by propensity weights (see Supplementary Fig. S1). Analyses unadjusted for propensity weights have similar results (see Supplementary Fig. S2). Interaction terms in interaction models (see “Materials and Methods”). tx, therapy.